PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
296.00
+14.00 (4.96%)
Nov 5, 2026, 3:40 PM WIB

IDX:DGNS Balance Sheet

Millions IDR. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,2798,4754,20910,24528,01144,720
Short-Term Investments
1,4581,458959.591,6962,5436,507
Cash & Short-Term Investments
12,7379,9335,16911,94130,55351,227
Cash Growth
184.54%92.17%-56.71%-60.92%-40.36%209.75%
Accounts Receivable
45,06846,27641,81038,28042,42241,730
Other Receivables
8,31910,4277,0796,9727,03332,209
Receivables
53,38756,70348,88945,25249,45573,939
Inventory
5,5296,0795,0435,1426,5677,760
Prepaid Expenses
37,265357.75275.79194.89266.08784.92
Other Current Assets
-18,12519,23125,27531,53220,153
Total Current Assets
108,91891,19878,60887,805118,373153,864
Property, Plant & Equipment
204,284209,420202,426164,248109,21987,107
Long-Term Investments
12,95112,95112,95112,9518,445-
Other Intangible Assets
2,6291,6701,353720.43681.12-
Long-Term Deferred Tax Assets
697.72697.72815.571,0311,0201,012
Other Long-Term Assets
2,7362,7363,8694,7192,198-
Total Assets
332,215318,672300,022271,475239,936241,983

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8,8808,9219,5516,0903,0784,524
Accrued Expenses
5,0266,4464,1163,1781,5563,125
Current Portion of Long-Term Debt
515.132,612152.08-1,701-
Current Portion of Leases
2,7324,3945,0123,7101,8112,390
Current Income Taxes Payable
-153.71255.12268.87674.8316,013
Current Unearned Revenue
2,0404,7781,748651.53893.77-
Other Current Liabilities
484.64310.34772.59545.72777.24576.26
Total Current Liabilities
19,67727,61521,60614,44410,49226,628
Long-Term Debt
49,09349,50844,81730,0009,358-
Long-Term Leases
19,17220,63220,40121,004409.042,888
Long-Term Unearned Revenue
6,0356,8007,820---
Pension & Post-Retirement Benefits
1,8181,5481,2922,1561,6863,103
Other Long-Term Liabilities
7,6458,5787,9548,2807,5637,563
Total Liabilities
103,440114,682103,89075,88529,50840,182

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
34,37531,25031,25031,25031,25031,250
Additional Paid-In Capital
62,83336,70736,70736,70736,70736,707
Retained Earnings
130,736135,202132,265131,518145,173132,509
Comprehensive Income & Other
831.26831.26-4,090-3,884-2,7021,335
Shareholders' Equity
228,775203,990196,132195,590210,428201,800
Total Liabilities & Equity
332,215318,672300,022271,475239,936241,983

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
71,51277,14670,38254,71413,2795,277
Net Cash (Debt)
-58,775-67,214-65,213-42,77317,27445,950
Net Cash Growth
-----62.41%229.33%
Net Cash Per Share
-45.49-53.77-52.17-34.2213.8237.04
Filing Date Shares Outstanding
1,3751,2501,2501,2501,2501,250
Total Common Shares Outstanding
1,3751,2501,2501,2501,2501,250
Working Capital
89,24163,58257,00273,361107,881127,236
Book Value Per Share
166.38163.19156.91156.47168.34161.44
Tangible Book Value
226,146202,320194,779194,870209,747201,800
Tangible Book Value Per Share
164.47161.86155.82155.90167.80161.44
Land
-60,80254,64343,65543,65543,655
Buildings
-82,773----
Machinery
-48,58646,44744,28539,54831,771
Construction In Progress
-13,62788,00153,06118,411311.4
Leasehold Improvements
-27,72127,85726,02623,67214,201